Our objectives were to define treatment success, compliance, and side effects for treatment
of Helicobacter pylori in clinical practice. In all, 224 consecutive patients received …

Helicobacter pylori infection can lead to gastritis, gastric and duodenal ulcers, and gastric
cancer. Consequently, complete eradication is the goal of therapy. First‐line therapy for H …

Helicobacter pylori (H. pylori) remains a prevalent, worldwide, chronic infection. Though the
prevalence of this infection appears to be decreasing in many parts of the world, H. pylori …

Main outcome measures. Culture and histology of antral biopsy specimens for determination
of H. pylori status. Results. Monotherapy with colloidal bismuth subcitrate (CBS) or …

In the treatment of Helicobacter pylori-associated peptic ulcer disease, the complexity (ie,
frequency and duration) of drug administration, the presence or development of bacterial …

Helicobacter pylori infection is a serious, chronic, transmissible, infectious disease in which
clinical disease typically is preceded by a long asymptomatic period. In many ways infection …

Objective: To assess effectiveness of treatment to cure Helicobacter pylori infection. Data
Synthesis: Meta‐analysis of 666 manuscripts (full papers, abstracts, letters to the editor) …

Background Bismuth‐containing quadruple therapy (BQT) is a recommended alternative first‐
line therapy for Helicobacter pylori (H. pylori) infection. We aim to evaluate the efficacy and …

Helicobacter pylori infection, which is present in 30-60% of the population in developed
countries and in more than 60% in developing countries, is established to be a major cause …

Background Amoxicillin, metronidazole, proton pump inhibitor, bismuth quadruple therapy
had been shown to reliably achieve high eradication rates. The role of individual …